On December 3, Gelonghui announced that Ark Health (06086.HK) has been selected to be included in the hang seng hong kong-listed biotech index, effective from December 9, 2024. The hang seng hong kong-listed biotech index aims to reflect the overall performance of biotechnology companies listed in Hong Kong.

The board of directors believes that the inclusion of the shares in the hang seng hong kong-listed biotech index can enhance the company's image among a wider range of investors and also create opportunities for the company's customers, partners, and investors to engage in the company's innovative internet plus-related health solutions.